title: Descemet membrane detachment after Nd: YAG laser capsulotomy in a patient with fuchs dystrophy.
abstract: OBJECTIVE
  Descemet membrane detachment (DMD) is uncommon. It most frequently occurs as a complication of intraocular surgery. The aim of this study was to report a case of DMD after neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy in a patient with Fuchs dystrophy.
  
  
  METHODS
  We describe the case of an 89-year-old man suffering from Fuchs dystrophy, who underwent cataract surgery on his left eye. Three years later, the patient presented with posterior capsule opacification, which was treated using Nd:YAG laser capsulotomy. The day after the procedure, the patient came back for emergency treatment because of an acute reduction in his vision caused by a DMD.
  
  
  RESULTS
  Fifteen days after an initial treatment involving the injection of air into the anterior chamber coupled with ocular paracentesis, clinical examination revealed a significant improvement in visual acuity, reduction in corneal edema, and reattachment of Descemet membrane. These findings were confirmed using anterior segment optical coherence tomography.
  
  
  CONCLUSIONS
  To our knowledge, this is the first reported case of DMD after Nd:YAG laser capsulotomy.
authors.affiliation: Department of Ophthalmology, Charles Nicolle Hospital, Rouen, France.
authors.forename: Mickaël
authors.initials: M
authors.lastname: Afriat
authors.forename: Julie
authors.initials: J
authors.lastname: Gueudry
authors.forename: Hela Yahia
authors.initials: HY
authors.lastname: Chérif
authors.forename: Elodie
authors.initials: E
authors.lastname: Maringe
authors.forename: Marc
authors.initials: M
authors.lastname: Muraine
mesh_terms: D000369:Aged, 80 and over; D058442:Capsule Opacification / Q000601:surgery*; D002386:Cataract / Q000150:complications*; D003886:Descemet Membrane / Q000293:injuries*; D005131:Eye Injuries / Q000209:etiology*; D005642:Fuchs' Endothelial Dystrophy / Q000150:complications*; D006801:Humans; D053844:Lasers, Solid-State / Q000627:therapeutic use; D008297:Male; D018918:Phacoemulsification; D064727:Posterior Capsulotomy / Q000009:adverse effects*; D012421:Rupture; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000209:etiology; D014792:Visual Acuity